Cargando…
Estimating the effect of sulfonylurea on HbA(1c) in diabetes: a systematic review and meta-analysis
AIMS/HYPOTHESIS: Sulfonylureas are widely prescribed glucose-lowering medications for diabetes, but the extent to which they improve glycaemia is poorly documented. This systematic review evaluates how sulfonylurea treatment affects glycaemic control. METHODS: Medline, EMBASE, the Cochrane Library a...
Autores principales: | Hirst, J. A., Farmer, A. J., Dyar, A., Lung, T. W. C., Stevens, R. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622755/ https://www.ncbi.nlm.nih.gov/pubmed/23494446 http://dx.doi.org/10.1007/s00125-013-2856-6 |
Ejemplares similares
-
HbA(1c) Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression
por: Bethel, M. Angelyn, et al.
Publicado: (2021) -
Sulfonylurea for the treatment of neonatal diabetes owing to K(ATP)-channel mutations: a systematic review and meta-analysis
por: Zhang, Hongliang, et al.
Publicado: (2017) -
Certain sulfonylurea drugs increase serum free fatty acid in diabetic patients: A systematic review and meta-analysis
por: Yu, Ming, et al.
Publicado: (2022) -
The bidirectional longitudinal association between depressive symptoms and HbA(1c): A systematic review and meta‐analysis
por: Beran, Magdalena, et al.
Publicado: (2021) -
Timings for HbA(1c) testing in people with diabetes are associated with incentive payments: an analysis of UK primary care data
por: Hirst, J. A., et al.
Publicado: (2018)